Is TransMedics Group, Inc. (TMDX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 11.7% / 30% | 11.0% / 30% | 1.9% / 30% | 2.1% / 5% | ✓ HALAL |
| DJIM | 11.7% / 33% | 11.0% / 33% | 1.9% / 33% | 2.1% / 5% | ✓ HALAL |
| MSCI | 48.6% / 33% | 45.7% / 33% | 7.9% / 33% | 2.1% / 5% | ✗ NOT HALAL |
| S&P | 11.7% / 33% | 11.0% / 33% | 1.9% / 33% | 2.1% / 5% | ✓ HALAL |
| FTSE | 48.6% / 33% | 45.7% / 33% | 7.9% / 50% | 2.1% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 59.9% | |
| Operating Margin | 13.2% | |
| Net Margin | 31.4% | |
| Return on Equity (ROE) | 54.2% | |
| Return on Assets (ROA) | 7.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $193M |
| Free Cash Flow | $134M |
| Total Debt | $519M |
| Debt-to-Equity | 109.8 |
| Current Ratio | 7.1 |
| Total Assets | $1.1B |
Price & Trading
| Last Close | $102.20 |
| 50-Day MA | $131.00 |
| 200-Day MA | $125.12 |
| Avg Volume | 816K |
| Beta | 2.0 |
|
52-Week Range
$62.23
| |
About TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Purification Calculator
As a halal stock with 2.10% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is TransMedics Group, Inc. (TMDX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), TransMedics Group, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is TransMedics Group, Inc.'s debt ratio?
TransMedics Group, Inc.'s debt ratio is 11.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 48.6%.
Does TransMedics Group, Inc. require dividend purification?
Yes, TransMedics Group, Inc. has an impermissible income ratio of 2.10%, which means 2.10% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are TransMedics Group, Inc.'s key financial metrics?
TransMedics Group, Inc. has a market capitalization of $3.4B, trailing P/E ratio of 20.3, and revenue of $605M. The company maintains a gross margin of 59.9% and a net margin of 31.4%. Return on equity stands at 54.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.